Why Ekso Bionics’ Price Target Just Moved Ekso Bionics Holdings just saw its price target reset to US$6, a level that bullish analysts link to the Q3 update and a view that the company is executing ...
Ekso Bionics will release its Q4 and full year 2024 financial results on March 3, 2025, with a conference call afterward. Ekso Bionics Holdings, Inc. announced that it will release its financial and ...
Earnings Call Insights: Ekso Bionics Holdings, Inc. (EKSO) Q2 2025 CEO Scott G. Davis opened by addressing the quarter’s performance, stating, "Our second quarter revenues were disappointing. But as ...
Ekso Bionics reports record Q4-2024 revenue of $5.1 million with improved gross margins and strategic distributor partnership. Ekso Bionics Holdings, Inc., a leader in exoskeleton technology, reported ...
Ekso Bionics Holdings Inc. (Nasdaq: EKSO), a San Rafael-based creator of robotic exoskeletal devices, announced last week $5.1 million in revenue for the fourth quarter. That’s a 5% increase year over ...
SAN RAFAEL, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced ...
SAN RAFAEL, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics (EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced it will showcase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results